MarketWatch Sep 26, 2024, 10:49:00 PM ...

Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

An exhibition of ecstatic, mystical work at the Halle Saint Pierre in Paris questions what is visionary, anti-pop, art brut, or art brutish.

See Cassava Sciences, Inc. (SAVA) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

SEC Filings provided by EDGAR Online, Inc.

Sava Šumanović's work has been offered at auction multiple times, with realized prices ranging from 950 USD to 40,653 USD, depending on the size and medium of the artwork. Since 2012 the record price ...

This data feed is not available at this time. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.

At close: June 18 at 4:00:01 p.m. EDT ...

At close: June 18 at 4:00:01 PM EDT ...